Neoadjuvant Therapy

Known as: Neoadjuvant Treatments, Treatments, Neoadjuvant, Induction Therapy 
Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
This is a pre-copyedited, author-produced version of an article accepted for publication in Annals of Oncology, following peer… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2017
Review
2017
Anti-HER2 treatment for HER2-positive breast cancer has changed the natural biology of this disease. This Series article reviews… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2017
Review
2017
PURPOSE We systematically review the benefits and harms of intravesical therapies for nonmuscle invasive bladder cancer… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE The exact definition of pathologic complete response (pCR) and its prognostic impact on survival in intrinsic breast… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND In a previous meta-analysis, we identified a survival benefit from neoadjuvant chemotherapy or chemoradiotherapy… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE The objective of this study was to determine whether the addition of trastuzumab to chemotherapy in the neoadjuvant… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Despite aggressive local therapy, patients with locally advanced bladder cancer are at significant risk for metastases… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE To define prognostic factors for response and long-term outcome for a wide spectrum of osteosarcomas, extending well… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE Expression of ErbB-1 and ErbB-2 (epidermal growth factor receptor and HER2/neu) in breast cancer may cause tamoxifen… (More)
Is this relevant?